drugset / Trial / NCT00140348
Dose Escalation and Efficacy Trial of GVAX® Prostate Cancer Vaccine
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate clinical and laboratory safety in patients receiving 4 different doses of GVAX® Prostate Cancer Vaccine in order to determine a maximum tolerated dose.
Timeline
- Start
- 2001-12
- Primary completion
- —
- Completion
- 2005-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GVAX® Prostate Cancer Vaccine | Vaccine | — | — |